Landscapes / Oncology

PD-(L)1 x VEGF bispecifics landscape

17 drugs in 187 active trials · Phase 2 and later · updated 16 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs17

DrugHow it worksCompanyStageNext dateDetails
PD-1/VEGF bispecific antibody
Akeso +1 · Public 9926.HK · SMMT
Approved in China 1 Dec 2026soonPhase 2 trial completes
PD-1/VEGF bispecific antibody
Junshi Biosciences · Public 1877.HK
Phase 3 27 Nov 2026soonPhase 2 trial completes
PD-L1/VEGF-A bispecific antibody
BioNTech +1 · Public BNTX · BMY
Phase 3 1 Jan 2027Phase 2 trial completes
PD-L1 antibody fused to a VEGFR1 domain (PD-L1/VEGF)
Huahai Pharmaceutical (Huaota) · Public 600521.SS
Phase 3 15 Jan 2027Phase 2 trial completes
PD-1/VEGF bispecific antibody
RemeGen +1 · Public 9995.HK · ABBV
Phase 3 12 May 2027Phase 2/3 trial completes
PD-1/VEGF bispecific antibody
Sinocelltech · Public 688520.SS
Phase 3 Jul 2027Phase 3 trial completes
PD-1/VEGF bispecific antibody
Pfizer +1 · Public PFE · 1530.HK
Phase 3 18 Oct 2027Phase 1/2 trial completes
PD-L1/VEGF bispecific antibody
Henlius · Public 2696.HK
Phase 2/3 30 Dec 2030Phase 2/3 trial completes
—
Phase 2 30 Dec 2026Phase 2 trial completes
PD-1/VEGF/CTLA-4 trispecific antibody
CStone · Public 2616.HK
Phase 1/2 Dec 2026First Phase 3 trials planned to start by end of 2026 (NSCLC, CRC, ES-SCLC; company plan)
PD-1/VEGF bispecific antibody
Merck & Co. +1 · Public MRK
Phase 2 Dec 2026Phase 1/2 trial completes
PD-L1/VEGF bispecific fusion protein
Tasly · Public 600535.SS
Phase 2 1 Jan 2027Phase 2 trial completes
PD-1/VEGF bispecific antibody
Crescent Biopharma +1 · Public CBIO · 6990.HK
Phase 1/2 Mar 2027Proof-of-concept data from the ASCEND Phase 1/2 trial expected in Q1 2027 (company guidance)
PD-1/VEGF bispecific antibody
OncoC4 · Private
Phase 1/2 30 Jun 2027Phase 1/2 trial completes
PD-L1/VEGF bispecific antibody
Instil Bio +1 · Public TIL · 1541.HK
Phase 2 23 Jul 2027Phase 2 trial completes
—
Phase 2 1 Apr 2028Phase 1/2 trial completes
PD-1/VEGFR2 bifunctional antibody
Ottimo Pharma · Private
Phase 1/2 Dec 2028Phase 1/2 trial completes

About this list

Matches
Conditions, trial titles, drug names and codes, other names, how it works and company.
Checked
17 of 17 drugs. How we check
Sources
ClinicalTrials.gov updated 16 Nov 2026 · openFDA updated 13 Nov 2026 · Company press releases
Ask your AI about this landscape. Connect it once, then ask in plain English.
Which PD-1/VEGF bispecifics are in Phase 3, and which trial reads out first?
Connect your AI

Which should we check next?

Need a landscape built for you? Talk to us.

Follow PD-1/VEGF

Following is part of Solo: you see every change to PD-1/VEGF the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in